Author: | Hudis, C. A. |
Article Title: | Introduction |
Keywords: | cancer survival; treatment outcome; drug tolerability; cancer recurrence; cancer combination chemotherapy; drug efficacy; risk benefit analysis; side effect; united states; drug targeting; cancer adjuvant therapy; cancer radiotherapy; cancer staging; antineoplastic agent; cancer palliative therapy; medical decision making; quality of life; breast cancer; anemia; prevalence; epidermal growth factor receptor 2; aromatase inhibitor; editorial; antineoplastic activity; cancer research; medical assessment; exemestane; patient care; cognitive defect; letrozole; metastasis potential; taxane derivative; anthracycline derivative; trastuzumab; anastrozole; breast surgery; recombinant erythropoietin; drug formulation; neuroprotection; symposium; hormone derivative; prognosis; human |
Journal Title: | Clinical Breast Cancer |
Volume: | 4 |
Issue: | Suppl.2 |
ISSN: | 1526-8209 |
Publisher: | Elsevier Inc. |
Date Published: | 2003-11-01 |
Start Page: | S69 |
Language: | English |
PROVIDER: | scopus |
DOI: | 10.3816/CBC.2003.s.017 |
DOI/URL: | |
Notes: | Export Date: 25 September 2014 -- Source: Scopus |